Philip Lee founded Cellasic Corp., Senti Biosciences, Inc. and Senti Biosciences, Inc.

He holds the position of Chief Technology Officer at Senti Biosciences, Inc. and Chief Technology Officer at Senti Biosciences, Inc.

In his past career Philip Lee was Chief Executive Officer at Cellasic Corp. and Head-Cell Culture Systems at Merck KGaA and Head-Cell Culture Systems at EMD Millipore Corp. (a subsidiary of Merck KGaA).

He received a doctorate from the University of California, Berkeley, a doctorate from The University of California, San Francisco and an undergraduate degree from Massachusetts Institute of Technology.